{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19428598", "DateCompleted": {"Year": "2009", "Month": "06", "Day": "22"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "02", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.antiviral.2009.02.001"], "Journal": {"ISSN": "1872-9096", "JournalIssue": {"Volume": "82", "Issue": "1", "PubDate": {"Year": "2009", "Month": "Apr"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection.", "Pagination": {"StartPage": "73", "EndPage": "81", "MedlinePgn": "73-81"}, "Abstract": {"AbstractText": ["We found that the butanol fraction of Cinnamomi Cortex (CC/Fr.2) showed moderate inhibitory activity in wild-type severe acute respiratory syndrome coronavirus (wtSARS-CoV) and HIV/SARS-CoV S pseudovirus infections. The inhibition on pseudovirus was also seen in cells pretreated with the CC and CC/Fr.2 (IC(50S), 283.4+/-16.3 and 149.5+/-13.5 microg/ml, respectively), however the highest activities on wtSARS-CoV were observed when the viruses were treated by the extracts before challenging (IC(50S), 43.1+/-2.8 and 7.8+/-0.3 microg/ml; SIs, 8.4 and 23.1, respectively). Among the compounds fractionated from CC, procyanidin A2 and procyanidin B1 showed moderate anti-wtSARS-CoV activity (IC(50S), 29.9+/-3.3 and 41.3+/-3.4 microM; SIs, 37.35 and 15.69, respectively). We also sought to determine whether they could interfere with the clathrin-dependent endocytosis pathway using transferrin receptor (TfR) as an indicator. CC/Fr.2 inhibited the internalization of TfR but the procyanidins did not. Taken together, CC/Fr.2 contains unknown substances, that could inhibit the infection, probably by interfering with endocytosis, and it also contains procyanidins that did not inhibit the internalization but inhibited the infection. Therefore, CC extracts contain anti-virus activities that act through distinct mechanisms according to differences in the compounds or mixtures."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Emerging Infectious Diseases, Department of Internal Medicine, Tohoku University, 980-8574, Japan."}], "Identifier": [], "LastName": "Zhuang", "ForeName": "Min", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jiang", "ForeName": "Hong", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Suzuki", "ForeName": "Yasuhiro", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Xiaoguang", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xiao", "ForeName": "Peng", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tanaka", "ForeName": "Takashi", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ling", "ForeName": "Hong", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yang", "ForeName": "Baofeng", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saitoh", "ForeName": "Hiroki", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Lianfeng", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Qin", "ForeName": "Chuan", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sugamura", "ForeName": "Kazuo", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hattori", "ForeName": "Toshio", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Butanols"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Proanthocyanidins"}, {"RegistryNumber": "0", "NameOfSubstance": "cinnamomi cortex"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Butanols"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cinnamomum zeylanicum"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Proanthocyanidins"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Severe acute respiratory syndrome-related coronavirus"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Severe Acute Respiratory Syndrome"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Baba M., Konno K., Shigeta S., De Clercq E. In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains. Eur. J. Clin. Microbiol. 1987;6:158\u2013160.", "ArticleIdList": ["3036498"]}, {"Citation": "Barnard D.L., Hubbard V.D., Burton J., Smee D.F., Morrey J.D., Otto M.J., Sidwell R.W. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and \u03b2-d-N4-hydroxycytidine. Antivir. Chem. Chemother. 2004;15:15\u201322.", "ArticleIdList": ["15074711"]}, {"Citation": "Barnard D.L., Day C.W., Bailey K., Heiner M., Montgomery R., Lauridsen L., Chan P.K., Sidwell R.W. Evaluation of immunomodulators, interferons and known in vitro SARS-CoV inhibitors for inhibition of SARS-CoV replication in BALB/c mice. Antivir. Chem. Chemother. 2006;17:275\u2013284.", "ArticleIdList": ["17176632"]}, {"Citation": "Beecher G.R. Proanthocyanidins: biological activities associated with human health. Pharm. Biol. 2004;42:2\u201320."}, {"Citation": "Brunet M.J., Blad\u00e9 C., Salvad\u00f3 M.J., Arola L. Human apo A-I and rat transferrin are the principal plasma proteins that bind wine catechins. J. Agric. Food Chem. 2002;50:2708\u20132712.", "ArticleIdList": ["11958645"]}, {"Citation": "Caraglia M., Libroia A.M., Corradino S., Coppola V., Guarrasi R., Barile C., Genua G., Bianco A.R., Tagliaferri P. Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells. Biochem. Biophys. Res. Commun. 1994;203:281\u2013288.", "ArticleIdList": ["8074667"]}, {"Citation": "Chen L., Gui C., Luo X., Yang Q., G\u00fcnther S., Scandella E., Drosten C., Bai D., He X., Ludewig B., Chen J., Luo H., Yang Y., Yang Y., Zou J., Thiel V., Chen K., Shen J., Shen X., Jiang H. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 2005;79:7095\u20137103.", "ArticleIdList": ["PMC1112131", "15890949"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Crotzer V.L., Mabardy A.S., Weiss A., Brodsky F.M. T cell receptor engagement leads to phosphorylation of clathrin heavy chain during receptor internalization. J. Exp. Med. 2004;199:981\u2013991.", "ArticleIdList": ["PMC2211883", "15067034"]}, {"Citation": "De Bruyne T., Pieters L., Witvrouw M., De Clercq E., Vanden Berghe D., Vlietinck A.J. Biological evaluation of proanthocyanidin dimers and related polyphenols. J. Nat. Prod. 1999;62:954\u2013958.", "ArticleIdList": ["10425115"]}, {"Citation": "De Clercq E. Antivirals and antiviral strategies. Nat. Rev. Microbiol. 2004;2:704\u2013720.", "ArticleIdList": ["PMC7097272", "15372081"]}, {"Citation": "De Clercq E. Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev. Anti. Infect. Ther. 2006;4:291\u2013302.", "ArticleIdList": ["PMC7105749", "16597209"]}, {"Citation": "Drosten C., G\u00fcnther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burgui\u00e8re A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., M\u00fcller S., Rickerts V., St\u00fcrmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1967\u20131976.", "ArticleIdList": ["12690091"]}, {"Citation": "Haagmans B.L., Kuiken T., Martina B.E., Fouchier R.A., Rimmelzwaan G.F., van Amerongen G., van Riel D., de Jong T., Itamura S., Chan K.H., Tashiro M., Osterhaus A.D. Pegylated IFN-\u03b1 protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 2004;10:290\u2013293.", "ArticleIdList": ["PMC7095986", "14981511"]}, {"Citation": "Heide R.T. Qualitative analysis of the essential oil of cassia (cinnamomum cassia blume) J. Agric. Food Chem. 1972;20:747\u2013752."}, {"Citation": "Ho T.Y., Wu S.L., Chen J.C., Li C.C., Hsiang C.Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2006;74:92\u2013101.", "ArticleIdList": ["PMC7114332", "16730806"]}, {"Citation": "Inoue Y., Tanaka N., Tanaka Y., Inoue S., Morita K., Zhuang M., Hattori T., Sugamura K. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J. Virol. 2007;81:8722\u20138729.", "ArticleIdList": ["PMC1951348", "17522231"]}, {"Citation": "Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J. SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1953\u20131966.", "ArticleIdList": ["12690092"]}, {"Citation": "Lee K.H., Kashiwada Y., Nonaka G.I., Nishioka I., Nishizawa M., Yamagishi T., Bodner A.J., Kilkuskie R.E., Chen Y.C. In: Tannis and Related Compounds as Anti-HIV Agents. Natural Products as Antiviral Agents. Chu C.K., Cutler H.G., editors. Plenum Press; New York: 1992. pp. 69\u201390."}, {"Citation": "Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.J., Woodle M.C., Zhong N., Lu P.Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 2005;11:944\u2013951.", "ArticleIdList": ["PMC7095788", "16116432"]}, {"Citation": "Li S.Y., Chen C., Zhang H.Q., Guo H.Y., Wang H., Wang L., Zhang X., Hua S.N., Yu J., Xiao P.G., Li R.S., Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67:18\u201323.", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u2013454.", "ArticleIdList": ["PMC7095016", "14647384"]}, {"Citation": "Lingappa J.R., McDonald L.C., Simone P., Parashar U.D. Wresting SARS from uncertainty. Emerg. Infect. Dis. 2004;10:167\u2013170.", "ArticleIdList": ["PMC3086179", "15040341"]}, {"Citation": "Liu X., Zhang M., He L., Li Y., Kang Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS) Cochrane Database Syst. Rev. 2006 CD004882.", "ArticleIdList": ["16437501"]}, {"Citation": "Marsh M., Helenius A. Virus entry: open sesame. Cell. 2006;124:729\u2013740.", "ArticleIdList": ["PMC7112260", "16497584"]}, {"Citation": "Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 1996;12:575\u2013625.", "ArticleIdList": ["8970738"]}, {"Citation": "Naldini L., Bl\u00f6mer U., Gage F.H., Trono D., Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 1996;93:11382\u201311388.", "ArticleIdList": ["PMC38066", "8876144"]}, {"Citation": "Naslavsky N., Weigert R., Donaldson J.G. Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol. Biol. Cell. 2004;15:3542\u20133552.", "ArticleIdList": ["PMC491817", "15146059"]}, {"Citation": "Nonaka G., Morimoto S., Nishioka I. Tannins and related compounds. Part 13. Isolation and structures of trimeric, tetrameric and pentameric proanthicyanidins from cinnamon. J. Chem. Soc., Perkin Trans. 1983;1:2139\u20132145."}, {"Citation": "Paragas J., Blatt L.M., Hartmann C., Huggins J.W., Endy T.P. Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models. Antiviral Res. 2005;66:99\u2013102.", "ArticleIdList": ["PMC7114208", "15911026"]}, {"Citation": "Prior R.L., Gu L. Occurrence and biological significance of proanthocyanidins in the American diet. Phytochemistry. 2005;66:2264\u20132280.", "ArticleIdList": ["15904940"]}, {"Citation": "Scalbert A., D\u00e9prez S., Mila I., Albrecht A.M., Huneau J.F., Rabot S. Proanthocyanidins and human health: systemic effects and local effects in the gut. Biofactors. 2000;13:115\u2013120.", "ArticleIdList": ["11237169"]}, {"Citation": "Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 2004;101:4240\u20134245.", "ArticleIdList": ["PMC384725", "15010527"]}, {"Citation": "Sun X., Yau V.K., Briggs B.J., Whittaker G.R. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology. 2005;338:53\u201360.", "ArticleIdList": ["15936793"]}, {"Citation": "Tan E.L., Ooi E.E., Lin. C.Y., Tan H.C., Ling A.E., Lim B., Stanton L.W. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg. Infect. Dis. 2004;10:581\u2013586.", "ArticleIdList": ["PMC3323075", "15200845"]}, {"Citation": "Xu H.X., Wan M., Dong H., But P.P.H., Foo L.Y. Inhibitory activity of flavonoids and tannis against HIV-1 protease. Biol. Pharm. Bull. 2000;23:1072\u20131076.", "ArticleIdList": ["10993207"]}, {"Citation": "Xu X., Sutak R., Richardson D.R. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking. Mol. Pharmacol. 2008;73:833\u2013844.", "ArticleIdList": ["18029550"]}, {"Citation": "Xu Y., Zhang X., Matsuoka M., Hattori T. The possible involvement of CXCR4 in the inhibition of HIV-1 infection mediated by DP178/gp41. FEBS Lett. 2000;487:185\u2013188.", "ArticleIdList": ["11150506"]}, {"Citation": "Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O., Subbarao K., Nabel G.J. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 2004;78:5642\u20135650.", "ArticleIdList": ["PMC415834", "15140961"]}, {"Citation": "Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., Zhang H., Luo H., Zhu L., Jiang P., Chen L., Shen Y., Luo M., Zuo G., Hu J., Duan D., Nie Y., Shi X., Wang W., Han Y., Li T., Liu Y., Ding M., Deng H., Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004;78:11334\u201311339.", "ArticleIdList": ["PMC521800", "15452254"]}, {"Citation": "Zhang M.M., Liu X.M., He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J. Gastroenterol. 2004;10:3500\u20133505.", "ArticleIdList": ["PMC4576235", "15526373"]}]}], "History": [{"Year": "2008", "Month": "9", "Day": "6"}, {"Year": "2009", "Month": "1", "Day": "3"}, {"Year": "2009", "Month": "2", "Day": "5"}, {"Year": "2009", "Month": "5", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "5", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "6", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "2", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19428598", "PMC7114128", "10.1016/j.antiviral.2009.02.001", "S0166-3542(09)00029-1"]}}], "PubmedBookArticle": []}